BioNexus Gene Lab invests RM1.2M for 10% stake in Malaysian digital health firm AISB

BioNexus Gene Lab Corp

Investment of RM1.2M (~$250k) via subsidiary MRNA Scientific for ~10% equity in Ascension Innovation (AISB).
Funding to accelerate AISB's AI platform aiCMS with predictive analytics, AI diagnosis aids, and more.
AISB projects revenue of RM75M collectively for 2024-2028; currently 145k+ users and 30+ providers.
Investment supports BGLC's genomic diagnostics integration into AISB's platform to expand market reach.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.